financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Strong Sell Opinion On Shares Of Xpeng Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Strong Sell Opinion On Shares Of Xpeng Inc.
Mar 24, 2025 10:54 AM

01:35 PM EDT, 03/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We maintain our USD8 target (2x 2025 P/B) and Strong Sell rating on XPeng ( XPEV ). The company reported 2024 revenue growth of 33.2% to CNY40.87B, with gross margin improving significantly to 14.3% (vs. 1.5% in 2023) and vehicle margin turning positive at 8.3% (from -1.6%). Full-year net loss narrowed to CNY5.79B from CNY10.38B in 2023, with Q4 2024 showing particular strength -- deliveries surged 52.1% Y/Y to 91,507 vehicles, driving quarterly revenue up 23.4% Y/Y to CNY16.11B. However, we forecast 2025 LPS of -CNY2.79 (down from -CNY4.80), while improving to EPS of CNY1.06 in 2026, as ongoing industry price wars and substantial R&D investments (CNY6.46B in 2024, +22.4% Y/Y) continue pressuring margins. While XPeng's ( XPEV ) liquidity position remains adequate (CNY41.96B cash), we see risks from intensifying competition and the need for continued heavy investment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Maintains Buy Opinion On Shares Of Guardant Health, Inc.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Guardant Health, Inc.
May 24, 2024
11:55 AM EDT, 05/24/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price by $3 to $28, reflecting a 3.5x multiple of our 2025 revenue estimate, a discount to GH's historical average due to a long horizon...
Research Alert: CFRA Maintains Hold Opinion On Booz Allen Hamilton Holding Corporation
Research Alert: CFRA Maintains Hold Opinion On Booz Allen Hamilton Holding Corporation
May 24, 2024
01:20 PM EDT, 05/24/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month target price to $165 from $150, on a P/E of 25.1x our FY 2026 (Mar.) EPS forecast, a premium to both BAH's three-year historical average and...
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Netflix, Inc.
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Netflix, Inc.
May 24, 2024
12:20 PM EDT, 05/24/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our target to $725 from $640 on a forward TEV/EBITDA of 26.3x our 2025 EBITDA estimate at $28.14/share, a premium to the peer average at 23.0x and below...
Research Alert: CFRA Keeps Buy Opinion On Adss Of Pdd Holdings Inc.
Research Alert: CFRA Keeps Buy Opinion On Adss Of Pdd Holdings Inc.
May 24, 2024
01:45 PM EDT, 05/24/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our target price to USD200 from USD155, 13x our 2024 EV/EBITDA (peer median: 11x), on a projected ROE of 51% in 2024 (peer median: 20%). Q1 2024 EPADS...
Copyright 2023-2026 - www.financetom.com All Rights Reserved